HIMS scales personalized care, expands globally and invests in technology as it balances growth with evolving profitability.

Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term losses from the stock lately, despite its bumpy ride over recent months. The San Francisco, CA-based health and ...

Hims & Hers Health (HIMS) has entered into an agreement to acquire YourBio Health, a Boston-based maker of capillary whole blood sampling technology. Financial terms weren’t disclosed. The all-cash ...

Hims & Hers Health, Inc. (NYSE: HIMS) on Wednesday agreed to acquire YourBio Health, Inc., a Boston-based provider of capillary whole blood sampling technology. YourBio Health develops technologies ...

Hims & Hers Health (HIMS) is attracting attention as investors size up its performance after recent share price movement. Over the past month, shares have fallen 17%, prompting questions about ...

Below is Validea's guru fundamental report for HIMS & HERS HEALTH INC (HIMS). Of the 22 guru strategies we follow, HIMS rates highest using our Value Investor model based on the published strategy of ...

A Fool since 2019, and a graduate of Cal State LA with a B.S. in Finance and M.A. in Economics. Parkev is an adjunct professor of Finance and enjoys reading about financial and economic history.

Hims & Hers maintains its long-term Buy rating, despite recent stock volatility and slower subscriber growth. HIMS continues to expand its platform beyond GLP-1s, investing heavily in verticalization ...